Liu L - Search Results

1

A novel molecular and clinical staging model to predict survival for patients with esophageal squamous cell carcinoma.

Wang W, Wang Z, Zhao J, Wei M, Zhu X, He Q, Ling T, Chen X, Cao Z, Zhang Y, Liu L, Shi M. Wang W, et al. Among authors: liu l. Oncotarget. 2016 Sep 27;7(39):63526-63536. doi: 10.18632/oncotarget.11362. Oncotarget. 2016. PMID: 27556859 Free PMC article.

2

Preoperative serum TMAO level is a new prognostic marker for colorectal cancer.

Liu X, Liu H, Yuan C, Zhang Y, Wang W, Hu S, Liu L, Wang Y. Liu X, et al. Among authors: liu h, liu l. Biomark Med. 2017 May;11(5):443-447. doi: 10.2217/bmm-2016-0262. Biomark Med. 2017. PMID: 28621609

3

Potential diagnostic and prognostic marker dimethylglycine dehydrogenase (DMGDH) suppresses hepatocellular carcinoma metastasis in vitro and in vivo.

Liu G, Hou G, Li L, Li Y, Zhou W, Liu L. Liu G, et al. Among authors: liu l. Oncotarget. 2016 May 31;7(22):32607-16. doi: 10.18632/oncotarget.8927. Oncotarget. 2016. PMID: 27119355 Free PMC article.

4

Preoperative Cryopreservation Promotes Digital Survival after Digit Replantation.

Tian Y, Li N, Wang W, Liu L. Tian Y, et al. Among authors: liu l. Comput Math Methods Med. 2022 Mar 7;2022:2003618. doi: 10.1155/2022/2003618. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Sep 27;2023:9852759. doi: 10.1155/2023/9852759. PMID: 35295200 Free PMC article. Retracted. Clinical Trial.

5

Identification of breast cancer recurrence risk factors based on functional pathways in tumor and normal tissues.

Chen X, Liu L, Wang Y, Liu B, Zeng D, Jin Q, Li M, Zhang D, Liu Q, Xie H. Chen X, et al. Among authors: liu l, liu b, liu q. Oncotarget. 2017 Mar 28;8(13):20679-20694. doi: 10.18632/oncotarget.11557. Oncotarget. 2017. PMID: 27564264 Free PMC article.

6

Predicting hepatocellular carcinoma through cross-talk genes identified by risk pathways.

Liu L, Pang L, Wang Y, Hu M, Shao Z, Huo D, Zhang D, Xie H, Yang J, Liu Q, Chen X. Liu L, et al. Among authors: liu q. Oncotarget. 2018 Apr 20;9(30):21259-21267. doi: 10.18632/oncotarget.24915. eCollection 2018 Apr 20. Oncotarget. 2018. PMID: 29765536 Free PMC article.

7

An ensemble prognostic model for colorectal cancer.

Li BQ, Huang T, Zhang J, Zhang N, Huang GH, Liu L, Cai YD. Li BQ, et al. Among authors: liu l. PLoS One. 2013 May 2;8(5):e63494. doi: 10.1371/journal.pone.0063494. Print 2013. PLoS One. 2013. PMID: 23658834 Free PMC article.

8

Prediction on the risk population of idiosyncratic adverse reactions based on molecular docking with mutant proteins.

Xie H, Zeng D, Chen X, Huo D, Liu L, Zhang D, Jin Q, Ke K, Hu M. Xie H, et al. Among authors: liu l. Oncotarget. 2017 Oct 5;8(56):95568-95576. doi: 10.18632/oncotarget.21509. eCollection 2017 Nov 10. Oncotarget. 2017. PMID: 29221149 Free PMC article.

9

Precision treatment exploration of breast cancer based on heterogeneity analysis of lncRNAs at the single-cell level.

Zhang Y, Zhang D, Meng Q, Liu Z, Xie H, Liu L, Xu F, Chen X. Zhang Y, et al. Among authors: liu z, liu l. BMC Cancer. 2021 Aug 13;21(1):918. doi: 10.1186/s12885-021-08617-7. BMC Cancer. 2021. PMID: 34388989 Free PMC article.

10

TF-centered downstream gene set enrichment analysis: Inference of causal regulators by integrating TF-DNA interactions and protein post-translational modifications information.

Liu Q, Tan Y, Huang T, Ding G, Tu Z, Liu L, Li Y, Dai H, Xie L. Liu Q, et al. Among authors: liu l. BMC Bioinformatics. 2010 Dec 14;11 Suppl 11(Suppl 11):S5. doi: 10.1186/1471-2105-11-S11-S5. BMC Bioinformatics. 2010. PMID: 21172055 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72,778 results

Search Page

Filters